A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer

Clinical trial NCT01744340 · COMPLETED

Trial details

NCT number: NCT01744340
Sponsor: howard safran
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Colon Cancer

Start date: 2012-05-01
Primary completion: 2015-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.